Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can we Use a Simple Blood Test to Reduce Unnecessary Adverse Effects From Radiotherapy by Timely Identification of Radiotherapy-resistant Rectal Cancers? MeD-Seq Rectal Study

NCT06035471 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06035471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06035471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can we Use a Simple Blood Test to Reduce Unnecessary Adverse Effects From Radiotherapy by Timely Identification of Radiotherapy-resistant Rectal Cancers? MeD-Seq Rectal Study
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2023
Completion date
June 1, 2027
Enrollment
75 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pathological response rate, circulating tumour dna